CHAI, in collaboration with Aurum Institute, Unitaid, and the Bill & Melinda Gates Foundation, is pleased to announce a call for expressions of interest (EOI) for suppliers who can provide a viable, affordable, quality-assured solution for the low- and middle-income country market to accelerate widespread access to CD4 testing, cryptococcus, and histoplasmosis infection screening. Interested manufacturers should provide evidence and plans to scale up access to currently available POC CD4 testing options and/or CrAg or Histoplasmosis screening before the end of 2025, while manufacturers with tests in the pipeline should provide evidence and plans to bring these tests to market by the end of 2026.
- EOIs should be submitted via e-mail with the subject line “Expression of Interest – AHD”, to AHDDx@clintonhealthaccess.org, and include both the cover letter and the completed excel annex document
- Closing Date: August 2, 2024
